EUVIMEDEUVIMED entdecken
Crossref

Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren’s disease

Loïc Meudec, Negaar Goudarzi, Sacha E Silva-Saffar, Juliette Pascaud, Fanny Jaulin, Quentin Pascal, Thierry Lazure, Rami Bechara, Xavier Mariette, Gaetane Nocturne

Annals of the Rheumatic Diseases · 2025

DOI: 10.1016/j.ard.2025.04.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025. Verfasst von Loïc Meudec und 9 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Inserm UMR 1…. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Organoids, Salivary Glands, Salivary Glands, Minor. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Fondation Arthritis, French National Research Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Salivary gland epithelial cells (SGECs) play a key role in Sjögren's disease (SjD) as an active contributor to the pathogenesis. Current models lack clear epithelial readouts. Our aim was to establish a more advanced model by developing salivary gland organoids (SGOs) from labial salivary gland biopsies (LSGBs) of SjD patients and sicca controls. METHODS: We included SjD patients fulfilling the American College of Rheumatology/European League Against Rheumatism 2016 criteria and sicca controls. LSGBs were dissociated, encapsulated in extracellular matrix, and submerged in growth expansion medium for long-term culture. SGOs were primarily cultured in differentiation medium and then transferred to a low attachment plate to form differentiated SGOs (DIF-SGOs). RESULTS: We included 13 SjD and 15 controls. In both groups, SGOs were formed, demonstrating long-term culture viability and comparable self-renewal capacity (3.3 ± 1.7 months). DIF-SGOs comparably exhibited mature acinar (aquaporin 5, amylase), ductal (cytokeratins 5 and 7) and myoepithelial (α-smooth muscle actin) markers in both groups. DIF-SGOs were responsive to inflammation by expressing BAFF, CXCL10 and IL7 upon stimulation with poly(I:C) and interferon-α. DIF-SGOs also demonstrated a swelling response to cholinergic stimulation by pilocarpine. We observed significant differences between SjD- and control-derived SGOs. Notably, SjD-derived DIF-SGOs consistently maintained a persistent interferon signature throughout long-term culture. In addition, the swelling capacity was reduced in SjD-derived DIF-SGOs compared to control. However, treatment with tofacitinib enhanced the swelling ability, suggesting a potential effect on saliva production. CONCLUSIONS: We successfully developed SGOs from LSGBs of SjD patients, allowing long-term culture and faithfully recapitulating the disease phenotype. This model holds promise as a valuable tool for drug screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeOrganoidsSalivary GlandsSalivary Glands, MinorHumansFemaleMiddle AgedBiopsyMaleAdultCase-Control StudiesEpithelial CellsCell DifferentiationCells, CulturedCell Culture TechniquesAged

Autor:innen und Institutionen

  • Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Inserm UMR 1184, Le Kremlin-Bicêtre, France.
  • Institut Gustave Roussy, INSERM U1279, Patient-Derived Cancer Organoids Platform, Université Paris Saclay, Villejuif, France.
  • Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Le Kremlin-Bicêtre, France.
  • Department of pathology, AP-HP, GHU Paris Saclay, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Inserm UMR 1184, Le Kremlin-Bicêtre, France; Department of immuno-rhumatology, FHU…

Förderung

  • Commissariat à l'Énergie Atomique et aux Énergies Alternatives
  • Fondation Arthritis
  • French National Research Agency
  • Institut National de la Santé et de la Recherche Médicale
  • Andy Hill CARE Fund
  • Fondation pour la Recherche Médicale
  • Yonsei University College of Medicine
  • Société Française de Rhumatologie

Zitieren

APA

Meudec, L., Goudarzi, N., Silva-Saffar, S. E., Pascaud, J., Jaulin, F., Pascal, Q., Lazure, T., Bechara, R., Mariette, X., & Nocturne, G. (2025). Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren’s disease. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.04.020

Vancouver

Meudec L, Goudarzi N, Silva-Saffar SE, Pascaud J, Jaulin F, Pascal Q, et al. Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren’s disease. Annals of the Rheumatic Diseases. 2025. doi:10.1016/j.ard.2025.04.020

BibTeX
@article{Meudec2025,
  author = {Meudec, Loïc and Goudarzi, Negaar and Silva-Saffar, Sacha E and Pascaud, Juliette and Jaulin, Fanny and Pascal, Quentin and Lazure, Thierry and Bechara, Rami and Mariette, Xavier and Nocturne, Gaetane},
  title = {Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren’s disease},
  journal = {Annals of the Rheumatic Diseases},
  year = {2025},
  doi = {10.1016/j.ard.2025.04.020}
}
Kostenlos starten →